Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Low-calcium serum-free defined medium selects for growth of normal prostatic epithelial stem cells.

Litvinov IV, Vander Griend DJ, Xu Y, Antony L, Dalrymple SL, Isaacs JT.

Cancer Res. 2006 Sep 1;66(17):8598-607.

2.

Stem/progenitor and intermediate cell types and the origin of human prostate cancer.

Tokar EJ, Ancrile BB, Cunha GR, Webber MM.

Differentiation. 2005 Dec;73(9-10):463-73.

PMID:
16351690
3.

Human α(2)β(1)(HI) CD133(+VE) epithelial prostate stem cells express low levels of active androgen receptor.

Williamson SC, Hepburn AC, Wilson L, Coffey K, Ryan-Munden CA, Pal D, Leung HY, Robson CN, Heer R.

PLoS One. 2012;7(11):e48944. doi: 10.1371/journal.pone.0048944. Epub 2012 Nov 7.

4.

In vitro culturing and characteristics of transit amplifying epithelial cells from human prostate tissue.

Uzgare AR, Xu Y, Isaacs JT.

J Cell Biochem. 2004 Jan 1;91(1):196-205.

PMID:
14689591
5.

The role of androgen in determining differentiation and regulation of androgen receptor expression in the human prostatic epithelium transient amplifying population.

Heer R, Robson CN, Shenton BK, Leung HY.

J Cell Physiol. 2007 Sep;212(3):572-8. Erratum in: J Cell Physiol. 2008 Apr;215(1):283-4.

PMID:
17541959
6.

Role of notch-1 and E-cadherin in the differential response to calcium in culturing normal versus malignant prostate cells.

Dalrymple S, Antony L, Xu Y, Uzgare AR, Arnold JT, Savaugeot J, Sokoll LJ, De Marzo AM, Isaacs JT.

Cancer Res. 2005 Oct 15;65(20):9269-79.

7.

Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens.

Miki J, Furusato B, Li H, Gu Y, Takahashi H, Egawa S, Sesterhenn IA, McLeod DG, Srivastava S, Rhim JS.

Cancer Res. 2007 Apr 1;67(7):3153-61.

8.
9.

Primary prostate cancer cultures are models for androgen-independent transit amplifying cells.

Bühler P, Wolf P, Katzenwadel A, Schultze-Seemann W, Wetterauer U, Freudenberg N, Elsässer-Beile U.

Oncol Rep. 2010 Feb;23(2):465-70.

PMID:
20043108
10.

Induced pluripotency of human prostatic epithelial cells.

Zhao H, Sun N, Young SR, Nolley R, Santos J, Wu JC, Peehl DM.

PLoS One. 2013 May 22;8(5):e64503. doi: 10.1371/journal.pone.0064503. Print 2013.

11.

Both retinoids and androgens are required to maintain or promote functional differentiation in reaggregation cultures of human prostate epithelial cells.

Goossens K, Deboel L, Swinnen JV, Roskams T, Manin M, Rombauts W, Verhoeven G.

Prostate. 2002 Sep 15;53(1):34-49.

PMID:
12210478
12.

Androgens regulate the immune/inflammatory response and cell survival pathways in rat ventral prostate epithelial cells.

Asirvatham AJ, Schmidt M, Gao B, Chaudhary J.

Endocrinology. 2006 Jan;147(1):257-71. Epub 2005 Sep 29.

PMID:
16195407
13.

Prostate specific antigen and androgen receptor induction and characterization of an immortalized adult human prostatic epithelial cell line.

Webber MM, Bello D, Kleinman HK, Wartinger DD, Williams DE, Rhim JS.

Carcinogenesis. 1996 Aug;17(8):1641-6.

14.

Generation of active TGF-beta by prostatic cell cocultures using novel basal and luminal prostatic epithelial cell lines.

Salm SN, Koikawa Y, Ogilvie V, Tsujimura A, Coetzee S, Moscatelli D, Moore E, Lepor H, Shapiro E, Sun TT, Wilson EL.

J Cell Physiol. 2000 Jul;184(1):70-9.

PMID:
10825235
15.

The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells.

Vander Griend DJ, Karthaus WL, Dalrymple S, Meeker A, DeMarzo AM, Isaacs JT.

Cancer Res. 2008 Dec 1;68(23):9703-11. doi: 10.1158/0008-5472.CAN-08-3084.

16.

Aging of the prostate epithelial stem/progenitor cell.

Zenzmaier C, Untergasser G, Berger P.

Exp Gerontol. 2008 Nov;43(11):981-5. doi: 10.1016/j.exger.2008.06.008. Epub 2008 Jul 2. Review.

PMID:
18639623
17.
18.

A novel neoplastic primary tumor-derived human prostate epithelial cell line.

Ko D, Gu Y, Yasunaga Y, Nakamura K, Srivastava S, Moul JW, Sesterhenn IA, McLeod DG, Arnstein P, Taylor DO, Hukku B, Rhim JS.

Int J Oncol. 2003 Jun;22(6):1311-7.

PMID:
12738999
19.

Intermediate basal cells of the prostate: in vitro and in vivo characterization.

Garraway LA, Lin D, Signoretti S, Waltregny D, Dilks J, Bhattacharya N, Loda M.

Prostate. 2003 May 15;55(3):206-18.

PMID:
12692787
20.

Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.

Denmeade SR, Sokoll LJ, Dalrymple S, Rosen DM, Gady AM, Bruzek D, Ricklis RM, Isaacs JT.

Prostate. 2003 Mar 1;54(4):249-57.

PMID:
12539223
Items per page

Supplemental Content

Write to the Help Desk